Literature DB >> 20069217

Effects of the use of MIG3 bioceramics fabrics use--long infrared emitter--in pain, intolerance to cold and periodic limb movements in post-polio syndrome.

Tatiana Mesquita e Silva1, Gustavo Antonio Moreira, Abrahão Augusto Juviniano Quadros, Márcia Pradella-Hallinan, Sergio Tufik, Acary Souza Bulle Oliveira.   

Abstract

UNLABELLED: The main post-polio syndrome (PPS) symptoms are new-onset weakness, new-onset atrophy, fatigue, cold intolerance, and pain associated with sleep disturbances. The polysomnographic study is the gold pattern to analyze sleep disorders.
OBJECTIVE: To assess pain, intolerance to cold and periodic limb movements (PLM) index before and after the use of MIG3 bioceramic fabrics over 4 weeks.
METHOD: 12 patients with PPS from UNIFESP/EPM. All patients were submitted to polysomnography and infra-red examinations with answered scales of pain and intolerance to cold before and after the use of MIG3 bioceramics fabrics.
RESULTS: There were significant decreases in pain and PLM index.
CONCLUSION: MIG3 bioceramic fabrics can help in the treatment of pain and PLM in PPS patients.

Entities:  

Mesh:

Year:  2009        PMID: 20069217     DOI: 10.1590/s0004-282x2009000600016

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

1.  Previous Acute Polio and Post-Polio Syndrome: Recognizing the Pathophysiology for the Establishment of Rehabilitation Programs.

Authors:  Marco Orsini; Jano Alves de Souza; Marco Antonio Araújo Leite; Silmar Teixeira; Arthur de Sá Ferreira; Victor Hugo Bastos; Marcos Rg de Freitas; Acary Bulle Oliveira
Journal:  Neurol Int       Date:  2015-03-09

2.  A twelve-week, four-arm, randomized, double-blind, placebo-controlled, phase 2 prospective clinical trial to evaluate the efficacy and safety of an anthroposophic multimodal treatment on chronic pain in outpatients with postpolio syndrome.

Authors:  Ricardo Ghelman; Ivete Y Akiyama; Valeria T de Souza; Jussara Falcão; Vera Orgolini; Jorge K Hosomi; Abrahão A J Quadros; Acary S B Oliveira
Journal:  Brain Behav       Date:  2020-03-11       Impact factor: 2.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.